Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous CD34+ Stem Cell Transplantation in Dilated Cardiomyopathy
NCT00629018Phase 2Completed
- Sponsor
- University Medical Centre Ljubljana
- Start
- May 2006
- Primary completion
- Apr 2013
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous CD34+ cells in dilated cardiomyopathy (DCM), sponsored by University Medical Centre Ljubljana. Started May 2006; status: completed.
02
Drugs
autologous CD34+ cells
03
Conditions
dilated cardiomyopathy (DCM)
Beyond the preview
Go deeper on NCT00629018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00629018.